The tangled and messy science of medicating female sex drives
In 2019 the FDA approved the women’s libido drug Vyleesi. But follow-up reviews and discussions show many caveats to how female sexual dysfunction and sex drive are measured.
In 2019 the FDA approved the women’s libido drug Vyleesi. But follow-up reviews and discussions show many caveats to how female sexual dysfunction and sex drive are measured.
The FDA has a stringent system for testing the safety and quality of COVID-19 vaccines. The recent Johnson & Johnson mix up is an example.
Two in five Americans say they don’t want a COVID-19 vaccine, which is a problem. Options made in the US, like Moderna and Pfizer, are more trusted than ones developed internationally, like AstraZeneca and Oxford.
Lower doses of many cancer drugs might work just as well, with fewer side effects and big savings, some oncologists say.
Before vaccines, physicians would blow smallpox scabs up people’s noses or stab them with pus-laced needles to build up their resistance to the virus.
Evidence on the Ebola antiviral holds promise, but we may not truly know how effective it’s distributed more widely under government approval.
Here’s a breakdown of what treatments are available for COVID-19, how they work, and under what circumstances they might be used.
While we may not know for sure how the president is faring, we do know some of his treatment protocol.
Hundreds of COVID-19 vaccine trials have been approved around the world over the past six months. And yet one group of patients—pregnant and lactating mothers—are being left out.
As the so-called “inactive” ingredients in medicines, excipients are often mistaken as being free from potential harm. But the evidence suggests otherwise.